Deals Of The Week: AZ/Merck, GSK/Concert, Microsoft/Merck
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Biomarkers For Alzheimer's, Parkinson's Disease To Be Developed By Industry Coalition Through First-Of-A-Kind Clinical Data Exchange
Unable to defeat Alzheimer's Disease and Parkinson's Disease, companies have joined forces to come up with new research tools
Biomarkers For Alzheimer's, Parkinson's Disease To Be Developed By Industry Coalition Through First-Of-A-Kind Clinical Data Exchange
Unable to defeat Alzheimer's Disease and Parkinson's Disease, companies have joined forces to come up with new research tools
New Initiatives to Improve Diagnostic Data Access
A welcome side-effect of the recent pharma trend towards streamlining, outsourcing, and establishing collaborative network strategies is the increasing availability of data and resources that others can draw upon more easily. The phenomenon is encouraging the formation of precompetitive alliances, often diagnostics focused, especially in oncology, where the vast majority of biomarker work has occurred.